Coronavirus
Johnson & Johnson’s COVID-19 vaccine reaches final trial stage
Johnson & Johnson’s COVID-19 vaccine isn’t the first to reach the final human trial stage, but it may have several advantages over its predecessors.
“Antibody inhaler” could rapidly treat—and prevent—COVID-19
Scientists have discovered a new antibody therapy that can be inhaled to provide treatment and temporary immunity to the coronavirus.
Antivenom scientists are using horse antibodies for COVID-19
In Costa Rica, horse antibodies for COVID-19 are about to enter human trials.
Scientists are developing a coronavirus breathalyzer test
Fast, accurate, cheap, and easy to use, a coronavirus breathalyzer could be a game changer — and multiple research teams are racing to get them approved.
Researchers found tiny COVID-19 antibodies in an alpaca
Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.
What we know about COVID-19 reinfection so far
Researchers have reported four cases of COVID-19 reinfection, with patients recovering from the coronavirus and later testing positive for another strain.
Robots are running COVID-19 drug development
IBM’s new online platform, RoboRXN, combines artificial intelligence, cloud computing, and robotics to automate the COVID-19 drug development process.
A patient’s sex may affect their COVID-19 immune response
Key differences in the COVID-19 immune response of men and women could potentially explain a disparity in patient outcomes.
The social distancing traffic light
Assessing your COVID-19 risk for everyday activities will be key to some kind of normalcy. Now, researchers want to add nuance to social distancing.
$5 COVID-19 test could be a game changer in the US
Abbott Laboratories’ $5 COVID-19 test has secured an FDA authorization, meaning the U.S. now has access to a fast, accurate antigen test.